CP
CROX icon

Camelot Portfolios’s Crocs CROX Stock Holding History

Camelot Portfolios’s Portfolio CROX Stock Details CROX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-200
Closed -$29.2K – 232
2024
Q2 		$29.2K Buy
+200
New +$28.1K 0.02% 344

Other funds holding CROX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WPA
WIT Partners Advisory Singapore $342M AUM 8.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Camelot Portfolios's CROX Position: Q3 2024 in Review

Camelot Portfolios sold out of Crocs (CROX) in Q3 2024, closing a stake of 200 shares — an estimated $29.2K sold.

Camelot Portfolios first reported a position in CROX in Q2 2024 and held it in 1 quarter. The position peaked at $29.2K in Q2 2024. 535 funds tracked by Wall St. Rank hold CROX as of Q3 2024.

  • Camelot Portfolios reported no remaining Crocs position as of Q3 2024 after selling out during the quarter.
  • Camelot Portfolios sold 200 Crocs shares in Q3 2024, an estimated $29.2K.
  • Camelot Portfolios first reported a position in Crocs in Q2 2024 and held it in 1 quarter.
  • Camelot Portfolios's Crocs position peaked at $29.2K in Q2 2024.
  • 535 funds tracked by Wall St. Rank held Crocs as of Q3 2024.

Based on Camelot Portfolios's 13F filing for Q3 2024, filed 12 Nov 2024.